The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

The EMA’s assessment confirms the treatment matches the reference drug in quality and performance, potentially expanding ...

The recommendation follows results showing markedly longer time to diagnosis of stage 3 T1D in treated patients, a condition ...

Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...

EU regulator says treatment could fill major gap for patients who lack a suitable stem cell donor and leads to sharp drops in ...

Karina Volkova trains in a clinic using a temporary permit that expires in 2027, giving her a narrow window to clear all ...

Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...

In Parkinson’s disease, early signs such as constipation, loss of smell, and REM sleep disturbance may appear up to a decade ...

An analysis of a German multicentre study reveals that women are more likely than men to receive inappropriate diagnostic ...

Prophylactic closure of defects after endoscopic submucosal dissection of the colon reduces delayed bleeding and may lower ...

A new digital wound care module assists clinicians in selecting appropriate dressings and generating standardized treatment ...

Somatic mutations with effects similar to those seen with VEXAS syndrome are increasingly seen as possible drivers of ...